Literature DB >> 16141345

The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study.

Elizabeta Nemeth1, Gloria C Preza, Chun-Ling Jung, Jerry Kaplan, Alan J Waring, Tomas Ganz.   

Abstract

Hepcidin is the principal iron-regulatory hormone. It acts by binding to the iron exporter ferroportin, inducing its internalization and degradation, thereby blocking cellular iron efflux. The bioactive 25 amino acid (aa) peptide has a hairpin structure stabilized by 4 disulfide bonds. We synthesized a series of hepcidin derivatives and determined their bioactivity in a cell line expressing ferroportin-GFP fusion protein, by measuring the degradation of ferroportin-GFP and the accumulation of ferritin after peptide treatment. Bioactivity was also assayed in mice by the induction of hypoferremia. Serial deletion of N-terminal amino acids caused progressive decrease in activity which was completely lost when 5 N-terminal aa's were deleted. Synthetic 3-aa and 6-aa N-terminal peptides alone, however, did not internalize ferroportin and did not interfere with ferroportin internalization by native hepcidin. Deletion of 2 C-terminal aa's did not affect peptide activity. Removal of individual disulfide bonds by pairwise substitution of cysteines with alanines also did not affect peptide activity in vitro. However, these peptides were less active in vivo, likely because of their decreased stability in circulation. G71D and K83R, substitutions previously described in humans, did not affect hepcidin activity. Apart from the essential nature of the N-terminus, hepcidin structure appears permissive for mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141345      PMCID: PMC1895343          DOI: 10.1182/blood-2005-05-2049

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs.

Authors:  Seth Rivera; Elizabeta Nemeth; Victoria Gabayan; Miguel A Lopez; Dina Farshidi; Tomas Ganz
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

2.  Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli.

Authors:  A Schmiedl; F Breitling; C H Winter; I Queitsch; S Dübel
Journal:  J Immunol Methods       Date:  2000-08-28       Impact factor: 2.303

3.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

4.  Design of salt-insensitive glycine-rich antimicrobial peptides with cyclic tricystine structures.

Authors:  J P Tam; Y A Lu; J L Yang
Journal:  Biochemistry       Date:  2000-06-20       Impact factor: 3.162

5.  Hepcidin, a urinary antimicrobial peptide synthesized in the liver.

Authors:  C H Park; E V Valore; A J Waring; T Ganz
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

6.  A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.

Authors:  C Pigeon; G Ilyin; B Courselaud; P Leroyer; B Turlin; P Brissot; O Loréal
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

7.  Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

Authors:  Alexander M Cole; Teresa Hong; Lee Ming Boo; Tung Nguyen; Chengquan Zhao; Greg Bristol; Jerome A Zack; Alan J Waring; Otto O Yang; Robert I Lehrer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.

Authors:  Gaël Nicolas; Myriam Bennoun; Arlette Porteu; Sandrine Mativet; Carole Beaumont; Bernard Grandchamp; Mario Sirito; Michèle Sawadogo; Axel Kahn; Sophie Vaulont
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

9.  LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.

Authors:  A Krause; S Neitz; H J Mägert; A Schulz; W G Forssmann; P Schulz-Knappe; K Adermann
Journal:  FEBS Lett       Date:  2000-09-01       Impact factor: 4.124

10.  The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.

Authors:  Howard N Hunter; D Bruce Fulton; Tomas Ganz; Hans J Vogel
Journal:  J Biol Chem       Date:  2002-07-22       Impact factor: 5.157

View more
  67 in total

Review 1.  Hepcidin and iron homeostasis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Biochim Biophys Acta       Date:  2012-01-26

Review 2.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

Review 3.  Liver iron sensing and body iron homeostasis.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

4.  Down-regulation of hepcidin in porphyria cutanea tarda.

Authors:  Richard S Ajioka; John D Phillips; Robert B Weiss; Diane M Dunn; Maria W Smit; Sean C Proll; Michael G Katze; James P Kushner
Journal:  Blood       Date:  2008-09-22       Impact factor: 22.113

5.  Serum hepcidin: a novel diagnostic tool in disorders of iron metabolism.

Authors:  Gaetano Bergamaschi; Laura Villani
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

6.  Impact of graphene-based nanomaterials (GBNMs) on the structural and functional conformations of hepcidin peptide.

Authors:  Krishna P Singh; Lokesh Baweja; Olaf Wolkenhauer; Qamar Rahman; Shailendra K Gupta
Journal:  J Comput Aided Mol Des       Date:  2018-02-03       Impact factor: 3.686

7.  Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.

Authors:  Jason S Troutt; Anthony M Butterfield; Robert J Konrad
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

Review 8.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 9.  The role of hepcidin in iron metabolism.

Authors:  Elizabeta Nemeth; Tomas Ganz
Journal:  Acta Haematol       Date:  2009-11-10       Impact factor: 2.195

10.  Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.

Authors:  Lavinia Oltiţa Brătescu; Liliana Bârsan; Liliana Gârneaţă; Ana Stanciu; Mariana Lipan; Simona Hildegard Stancu; Gabriel Mircescu
Journal:  Int Urol Nephrol       Date:  2014-03-29       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.